Wilmington Savings Fund Society’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03K Hold
200
﹤0.01% 1316
2026
Q1
$2.18K Hold
200
﹤0.01% 1344
2025
Q4
$2.59K Hold
200
﹤0.01% 1299
2025
Q3
$2.58K Sell
200
-161
-45% -$2.15K ﹤0.01% 1292
2025
Q2
$6.43K Hold
361
﹤0.01% 1720
2025
Q1
$6.43K Hold
361
﹤0.01% 1735
2024
Q4
$10.8K Hold
361
﹤0.01% 1643
2024
Q3
$5.64K Buy
+361
New +$6.55K ﹤0.01% 1760

Other funds holding NVCR

Wilmington Savings Fund Society's NVCR Position: Q2 2026 in Review

Wilmington Savings Fund Society held its NovoCure (NVCR) position steady in Q2 2026 at 200 shares worth $3.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.

Wilmington Savings Fund Society first reported a position in NVCR in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.8K in Q4 2024. 41 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Wilmington Savings Fund Society held 200 shares of NovoCure worth $3.03K as of Q2 2026.
  • Wilmington Savings Fund Society left its NovoCure share count unchanged in Q2 2026.
  • NovoCure made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1316 holding.
  • Wilmington Savings Fund Society first reported a position in NovoCure in Q3 2024 and has held it in 8 quarters since.
  • Wilmington Savings Fund Society's NovoCure position peaked at $10.8K in Q4 2024.
  • 41 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.